Scarica l'app Stockscreener
2.63
7.72%
-0.22
Precedente Chiudi:
$2.85
Aprire:
$2.88
Volume 24 ore:
496.18K
Relative Volume:
1.00
Capitalizzazione di mercato:
$350.43M
Reddito:
Utile/perdita netta:
$-18.86M
Rapporto P/E:
-0.1638
EPS:
-16.054
Flusso di cassa netto:
$-17.68M
1 W Prestazione:
+4.78%
1M Prestazione:
-18.07%
6M Prestazione:
-13.49%
1 anno Prestazione:
-23.32%
Intervallo 1D:
$2.55
$2.92
Intervallo di 1 settimana:
$2.025
$2.92
Portata 52W:
$0.92
$5.9599
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Nome
Indaptus Therapeutics Inc
Settore
Industria
Telefono
(646) 427-2727
Indirizzo
3 COLUMBUS CIRCLE, NEW YORK
Compare INDP vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
2.63 | 350.43M | 0 | -18.86M | -17.68M | -16.05 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Indaptus Therapeutics Inc Borsa (INDP) Ultime notizie
Indaptus Therapeutics Announces Securities Purchase Agreements and Private Placement for $2.135 Million - Quiver Quantitative
Indaptus Therapeutics Extends Timeline for Private Placement Financing - TipRanks
Indaptus Therapeutics Extends $24 Million Private Placement Closing to Oct. 16 - TradingView
Indaptus Therapeutics Announces Private Equity Financing Deal - TipRanks
Indaptus Therapeutics Shares Rise After Entering $24 Million Private Placement - marketscreener.com
Form 8K Indaptus Therapeutics Inc For: 10 September By Investing.com - Investing.com South Africa
Form 8K Indaptus Therapeutics Inc For: 10 September By Investing.com - Investing.com Nigeria
Form 8K Indaptus Therapeutics Inc For: 10 September By Investing.com - Investing.com Canada
Form 8K Indaptus Therapeutics Inc For: 10 September - Investing.com India
Form 8K Indaptus Therapeutics Inc For: 10 September By Investing.com - Investing.com UK
Indaptus Therapeutics Raises $24 Million in Private Placement of 20.3M Shares - TradingView
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Indaptus Therapeutics Secures $100 Million At-The-Market Equity Facility - Minichart
Indaptus Therapeutics, Inc. announced that it expects to receive $23.999989 million in funding - marketscreener.com
Indaptus Therapeutics Announces Routine Board Member Resignation - TipRanks
Indaptus Therapeutics, Inc. Announces Resignation of Tim Ruan from Director, Effective September 2, 2026 - marketscreener.com
Indaptus Therapeutics (INDP) updates $100M stock sale plan - Stock Titan
Indaptus Updates ATM Agreement to Expand Capital Flexibility - tipranks.com
Indaptus Therapeutics Launches $100 Million ATM Equity Program With H.C. Wainwright - TradingView
Indaptus sets up $100M at-the-market stock program - Stock Titan
September 2026's Top Stocks by Monthly Momentum - Stock Titan
Indaptus Therapeutics Launches $100M ATM Offering at $1.14 Per Share (NASDAQ: INDP) - Kalkine Media
Indaptus Therapeutics, Inc. SEC Filing (Aug 26, 2026) - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Indaptus Therapeutics Stock Price Forecast. Should You Buy INDP? - StockInvest.us
Short Interest in Indaptus Therapeutics, Inc. (NASDAQ:INDP) Declines By 64.1% - MarketBeat
Indaptus Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Indaptus Therapeutics Q2 EPS beats estimate as loss narrows - scanx.trade
Indaptus Therapeutics Reports Q2 Results Amid Strategic Pivot - TipRanks
Indaptus Therapeutics, Inc. 2Q 2026: Net loss $(1.79M), EPS $(0.02) — 10-Q Summary - TradingView
Indaptus Therapeutics (Nasdaq: INDP) cuts losses and raises $12M in Q2 - Stock Titan
Indaptus Q2 Net Loss Narrows to $1.8 Million - Quiver Quantitative
Indaptus Therapeutics (INDP) slashes R&D costs and bolsters cash after $12M raise - Stock Titan
Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - marketscreener.com
Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Yahoo Finance
Indaptus Therapeutics (INDP) Falls 14% to $1.02 — Biotech Micro-Cap Tests Critical SupportDescending Triangle - vinanet.vn
Indaptus Therapeutics (INDP) Q4 2025 Earnings: Wider-than-Expected Loss Amid No RevenueReturn On Equity - dars.gov.et
Indaptus Therapeutics (INDP) to Announce Earnings on Monday - MarketBeat
Qinglai Lu Net Worth (2026) - GuruFocus
Indaptus Therapeutics Inc (INDP) Stock News Today - TradingKey
Indaptus Therapeutics Inc (INDP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Indaptus Therapeutics (INDP) Slides 10.4% — Approaches Key Support at $1.23Ichimoku Entry - vinanet.vn
Indaptus Therapeutics (INDP) Slides 10.4% as Clinical-Stage Biotech Faces Selling PressureIchimoku Kumo Twist - vinanet.vn
INDP Q4 2025 Earnings: Wider-Than-Expected Loss Sends Shares Down 20.88%EPS Surprise History - vinanet.vn
Indaptus Therapeutics Inc (INDP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Indaptus Therapeutics Inc (INDP) Balance Sheet - TradingKey
Indaptus Therapeutics (INDP) Plunges 21% – Key Support Levels in FocusMFI Divergence - vinanet.vn
Indaptus Therapeutics Inc (INDP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Indaptus Therapeutics Inc (INDP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Indaptus Therapeutics Inc Azioni (INDP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):